We have a valuation range of $30 to $66 million for Red Mountain, with a preferred valuation of $52 million or $0.060/share (with a range from $0.034/share to $0.076/ share) - this does not include any value for the Company’s other projects or cash. This preferred valuation is well supported by values of recent transactions.

Kairos is concentrating activities on its two key areas – Roe Hills (gold) and the Pilbara Projects (lithium and gold) - This change in focus is supported by a number of recent major gold discoveries in Western Australia

The company has commenced a comprehensive clinical trial program that will see the initiation of 7 clinical trials throughout 2017. The first clinical trial is underway which focuses on using NOX66 in conjunction with chemotherapy on patients with late-stage cancers.

Early stage work by Mustang to date has resulted in the recovery of ~73,000 carats of reportedly high quality rubies from bulk sampling and prospecting, thought to be of similar quality to Gemfields high quality stones. The Company expects first revenue from rubies in October 2017, from a planned auction of 200,000ct

We have completed a valuation for White Cliff, with this resulting in a base case Company valuation of $32 million, or $0.017/share, a 180% premium to the current price.